Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

Phase 3

2(40.0%)

N/A

2(40.0%)

Phase 2

1(20.0%)

5Total

Phase 3(2)

N/A(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT00414115Recruiting

National Active Surveillance Network and Pharmacogenomics of Adverse Drug Reactions in Children

Role: collaborator

NCT03573830Not ApplicableCompleted

Randomized Control Trial of Booster Seat Education Material to Increase Perceived Benefit Among Parents

Role: collaborator

NCT02079090Phase 3Completed

Ketofol Versus Fentofol for Procedural Sedation in the Pediatric Emergency Department

Role: collaborator

NCT01456884Not ApplicableCompleted

Music Therapy for Pain Modification in Pediatric Palliative Care

Role: collaborator

NCT00486395Phase 3Terminated

Will CPAP Reduce Length Of Respiratory Support In Premature Infants?

Role: collaborator

NCT01247012Phase 2Unknown

Minimization of IntraLipid Versus Omegaven

Role: collaborator

All 6 trials loaded